Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease

Alzheimer's disease is associated with early synaptic loss. Specific nutrients are known to be rate limiting for synapse formation. Studies have shown that administering specific nutrients may improve memory function, possibly by increasing synapse formation. This Dutch study explores the Effect of a specific Nutritional Intervention on cerebral Glucose Metabolism in early Alzheimer's disease (NL‐ENIGMA, Dutch Trial Register NTR4718, http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4718). The NL‐ENIGMA study is designed to test whether the specific multinutrient combination Fortasyn Connect present in the medical food Souvenaid influences cerebral glucose metabolism as a marker for improved synapse function.

• Publication year

  2016

• Venue

  Alzheimer's & Dementia

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trci.2016.07.004PMID 29067310PMCID 5651347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A clinical trial investigating the effects of fortasyn connect (souvenaid) in prodromal Alzheimer’s disease: results of the LipiDiDiet study

  2016cited by this paper
• Lipid-Based Diets Improve Muscarinic Neurotransmission in the Hippocampus of Transgenic APPswe/PS1dE9 Mice.

  2015cited by this paper
• Specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats.

  2015cited by this paper
• Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease.

  2014cited by this paper
• Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis

  2014cited by this paper
• Special lipid-based diets alleviate cognitive deficits in the APPswe/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition.

  2014cited by this paper
• The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

  2014cited by this paper
• Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

  2014cited by this paper
• The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

  2014cited by this paper
• The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

  2013cited by this paper
• Nutritional approaches in the risk reduction and management of Alzheimer's disease.

  2013cited by this paper
• Mediterranean diet, stroke, cognitive impairment, and depression: A meta‐analysis

  2013cited by this paper
• Improved Spatial Learning Strategy and Memory in Aged Alzheimer AβPPswe/PS1dE9 Mice on a Multi-Nutrient Diet

  2013cited by this paper
• Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia: A 24-Week, Randomized, Clinical Trial

  2013cited by this paper
• Targeting Synaptic Dysfunction in Alzheimer's Disease by Administering a Specific Nutrient Combination

  2013cited by this paper
• Adherence to a Mediterranean diet and risk of incident cognitive impairment

  2013cited by this paper
• Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.

  2012cited by this paper
• Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial

  2012cited by this paper
• Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET

  2012cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Utility of imaging for nutritional intervention studies in Alzheimer's disease.

  2011cited by this paper
• Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment

  2011cited by this paper
• Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

  2010cited by this paper
• Use of phosphatide precursors to promote synaptogenesis.

  2009cited by this paper
• Low serum docosahexaenoic acid is a significant risk factor for alzheimer’s dementia

  2007cited by this paper
• Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.

  2007cited by this paper
• Effects of donepezil on cortical metabolic response to activation during 18FDG-PET in Alzheimer’s disease: a double-blind cross-over trial

  2006cited by this paper
• Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease

  2006cited by this paper
• Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.

  2005cited by this paper
• Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

  2004cited by this paper
• Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.

  2003cited by this paper
• Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

  2003cited by this paper
• Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study.

  2003cited by this paper
• Fish, meat, and risk of dementia: cohort study

  2002cited by this paper
• Alzheimer's Disease Is a Synaptic Failure

  2002cited by this paper
• Dietary intake of antioxidants and risk of Alzheimer disease.

  2002cited by this paper
• Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.

  2001cited by this paper
• Dietary fat intake and the risk of incident dementia in the Rotterdam study

  1997cited by this paper
• MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

  1987cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations

  1985cited by this paper
• Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

  1983cited by this paper
• [INTELLIGENCE AND RELIGIOUS PERSUASION].

  1964cited by this paper
• Validity of the Trail Making Test as an Indicator of Organic Brain Damage

  1958cited by this paper

• The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial

  2020cites this paper
• Mild Cognitive Impairment with a High Risk of Progression to Alzheimer’s Disease Dementia (MCI-HR-AD): Effect of Souvenaid® Treatment on Cognition and 18F-FDG PET Scans

  2019cites this paper
• Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

  2019cites this paper
• The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer’s disease: results from a randomized controlled trial

  2017cites this paper